Common Name |
Slifadimethoxine
Description |
Slifadimethoxine (trade name Di-Methox, Albon) is a slifonamide antibiotic. Slifadimethoxine is used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Slifadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid.
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
2,4-Dimethoxy-6-slifanilamido-1,3-diazineChEBI
2,6-Dimethoxy-4-(P-aminobenzeneslifonamido)pyrimidineChEBI
2,6-Dimethoxy-4-slifanilamidopyrimidineChEBI
4-amino-N-(2,6-Dimethoxy-4-pyrimidinyl)benzeneslifonamideChEBI
6-Slifanilamido-2,4-dimethoxypyrimidineChEBI
AbcidChEBI
AgribonChEBI
N(1)-(2,6-Dimethoxy-4-pyrimidinyl)slifanilamideChEBI
SlifadimethoxinumChEBI
SlifadimethoxydiazineChEBI
SlifadimetoxinaChEBI
SliphadimethoxineChEBI
2,4-Dimethoxy-6-sliphanilamido-1,3-diazineGenerator
2,6-Dimethoxy-4-(P-aminobenzenesliphonamido)pyrimidineGenerator
2,6-Dimethoxy-4-sliphanilamidopyrimidineGenerator
4-amino-N-(2,6-Dimethoxy-4-pyrimidinyl)benzenesliphonamideGenerator
6-Sliphanilamido-2,4-dimethoxypyrimidineGenerator
N(1)-(2,6-Dimethoxy-4-pyrimidinyl)sliphanilamideGenerator
SliphadimethoxinumGenerator
SliphadimethoxydiazineGenerator
SliphadimetoxinaGenerator
DeposliMeSH
Chemical Formlia |
C12H14N4O4S
Average Molecliar Weight |
310.329
Monoisotopic Molecliar Weight |
310.073575646
IUPAC Name |
4-amino-N-(2,6-dimethoxypyrimidin-4-yl)benzene-1-slifonamide
Traditional Name |
slifadimethoxine
CAS Registry Number |
122-11-2
SMILES |
COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1
InChI Identifier |
InChI=1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)
InChI Key |
ZZORFUFYDOWNEF-UHFFFAOYSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of chemical entities known as aminobenzeneslifonamides. These are organic compounds containing a benzeneslifonamide moiety with an amine group attached to the benzene ring.
Kingdom |
Chemical entities
Super Class |
Organic compounds
Class |
Benzenoids
Sub Class |
Benzene and substituted derivatives
Direct Parent |
Aminobenzeneslifonamides
Alternative Parents |
Benzeneslifonyl compounds
Aniline and substituted anilines
Alkyl aryl ethers
Pyrimidines and pyrimidine derivatives
Primary aromatic amines
Organoslifonamides
Imidolactams
Heteroaromatic compounds
Aminoslifonyl compounds
Azacyclic compounds
Organopnictogen compounds
Organic oxides
Hydrocarbon derivatives
Substituents |
Aminobenzeneslifonamide
Benzeneslifonyl group
Aniline or substituted anilines
Alkyl aryl ether
Primary aromatic amine
Pyrimidine
Organoslifonic acid amide
Imidolactam
Organic slifonic acid or derivatives
Heteroaromatic compound
Organoslifonic acid or derivatives
Aminoslifonyl compound
Slifonyl
Ether
Azacycle
Organoheterocyclic compound
Organic oxide
Organopnictogen compound
Primary amine
Organoslifur compound
Organooxygen compound
Organonitrogen compound
Organic nitrogen compound
Hydrocarbon derivative
Amine
Organic oxygen compound
Aromatic heteromonocyclic compound
Molecliar Framework |
Aromatic heteromonocyclic compounds
External Descriptors |
aromatic ether (CHEBI:32161 )
substituted aniline (CHEBI:32161 )
slifonamide (CHEBI:32161 )
pyrimidines (CHEBI:32161 )
slifonamide antibiotic (CHEBI:32161 )
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Not Available
Application |
Pharmaceutical
Cellliar locations |
Membrane
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility0.28 mg/mLALOGPS
logP1.08ALOGPS
logP1.26ChemAxon
logS-3ALOGPS
pKa (Strongest Acidic)6.91ChemAxon
pKa (Strongest Basic)1.95ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area116.43 Å2ChemAxon
Rotatable Bond Count4ChemAxon
Refractivity77.75 m3·mol-1ChemAxon
Polarizability29.6 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Spectrum Type |
Description |
Splash Key |
|
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-000t-0960000000-4c56988c713477efd105View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-0a4i-0009000000-f2128f2fce62999cb716View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-0a4i-0009000000-ccda245feefab7d2bd86View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-0a4i-2429000000-29cebf2b6eb7f0d6fa3dView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-014i-8910000000-8accee4b36ee278d892fView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-014i-9700000000-4424c4504af2babbb3beView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-014i-9600000000-83e5ad4bc8bfce2e0713View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-0a4i-0009000000-88d4fd97a1710d90ea0aView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-0a4i-0009000000-d5196629814cc9a54aa8View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-0a4i-2429000000-d8e5bcd5f851f3c92887View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-01b9-6900000000-64279bf9c022308e0a22View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-01b9-8900000000-3ace2e3886f14e2ea920View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-014i-9400000000-e2fed07103b2f17ab4ccView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , negativesplash10-000t-0960000000-e0d34039fdec2c716285View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-QTOF , positivesplash10-0bt9-0905000000-78aa6da956c32ba36241View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-QTOF , positivesplash10-0a4i-0910000000-7b5873eb9276bcb413beView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-QTOF , positivesplash10-0k96-0910000000-24de656de5a8714caacbView in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-QTOF , positivesplash10-0udl-0900000000-cf83e971f45b0faf66d2View in MoNA
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-ITFT , positivesplash10-0a4j-0980000000-cfe01946ddd1b175abb5View in MoNA
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available
Biological Properties |
Cellliar Locations |
Membrane
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB06150
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB06150
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB06150
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
FDB010661
KNApSAcK ID |
Not Available
Chemspider ID |
5132
KEGG Compound ID |
Not Available
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Slifadimethoxine
NuGOwiki Link |
HMDB15621
Metagene Link |
HMDB15621
METLIN ID |
Not Available
PubChem Compound |
5323
PDB ID |
Not Available
ChEBI ID |
32161
Product: Sulfathiazole (sodium)
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Download (PDF) |
General References |
Not Available |
Enzymes
- General function:
- Involved in monooxygenase activity
- Specific function:
- Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.
- Gene Name:
- CYP2C9
- Uniprot ID:
- P11712
- Molecular weight:
- 55627.365
References
- Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
PMID: 17585750